Molecular Imaging of Colorado (MIC), the wholly-owned subsidiary of statistically measured brain diagnostics company CereScan, is proud to announce it has joined Integrated Diagnostic Centers’ (IDC) metro Denver radiology network. The IDC relationship enables MIC to accept Physician Health Partners (PHP) patients and supports PHP’s commitment to providing superior cost-effective healthcare options.
During a two-day program for start-up companies on addressing the necessary fundamentals to transform technology into a viable company, CereScan’s CEO, John Kelley, joined other Denver business leaders in providing business basics to enable growth. Mr. Kelley, a recognized leader and mentor in the Denver area business community, shared his top fundamental learnings in building an effective, high caliber management team, and paralleled common traits of great managers and great leaders.
The nation’s leader in brain diagnostics will offer free consultations and qEEG brain mapping with every functional brain scan during the month of March.
In honor of Brain Injury Awareness Month, CereScan, the nation’s leader in providing statistically measured brain diagnostics, is taking steps to increase awareness about brain injuries by offering a discounted comprehensive brain diagnostic package to patients.
During the month of March, CereScan will offer free qEEG (Quantitative Electroencephalography) brain mapping – a $900 value — with every qSPECT brain scan appointment at its metro Denver location. The company will also provide free brain injury consultations to those concerned about lingering symptoms from past concussions.
Get this offer and start your path to better brain health today.
QEEG brain mapping is the latest diagnostic service to be offered by CereScan. In conjunction with the company’s qSPECT functional brain imaging, the two procedures provide a comprehensive look into how the brain is functioning. While SPECT imaging measures perfusion patterns (bloodflow) and pinpoints problem areas below the cortex, qEEG measures cortical electrical activity by measuring brainwaves.
“CereScan’s commitment to furthering awareness and providing hope to those suffering from traumatic brain injuries is incredibly inspiring and strong,” says John Kelley, CEO of CereScan. “Finding an answer for the women and men fighting these invisible wounds should be a priority every day of the year.”
Each year, nearly 1.7 million emergency department visits, hospitalizations or deaths are associated with traumatic brain injury, according to the Centers for Disease Control and Prevention (CDC). However, due to varying definitions and possible under-reporting, the exact rate at which concussions or mild traumatic brain injuries (TBIs) happen annually in the United States is not accurately known. CDC experts estimate as many as 3.8 million sports and recreation-related TBIs occur every year.
Traumatic brain injuries can affect the functionality of the brain and many times lead to psychological issues, such as nervousness, irritability, depression and mood swings. Due to the variety of symptoms that can result from a TBI, the condition is commonly misdiagnosed.
That’s where CereScan can make all the difference. CereScan’s qSPECT imaging technology goes beyond traditional diagnostic tools to review cerebral blood flow and cellular processes that help accurately diagnose traumatic brain injuries, helping physicians and patients create an effective treatment plan.
The company has been on the front lines in the identification and treatment of TBI through its Invisible Brain Injury Project in partnership with the Tug McGraw Foundation. In the study, CereScan first helped former military members assess the extent of their brain injury and then determine the efficacy of a new therapy by providing pre- and post-measurements and statistical analysis.
CereScan joins the Tug McGraw Foundation and the Colorado Neurological Institute to promote brain injury awareness month. To find out more about how you can support these organizations dedicated to enhancing the lives of those affected by brain injuries, visit TugMcGraw.org or TheCNI.org.
CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:
CereScan is one of 60 Colorado companies chosen from more than 280 applicants to participate in the first of its kind $100 million marketplace for impact investing
CereScan, the nation’s leader in providing statistically measured brain diagnostics, has been selected as one of the top 60 social ventures for the 2016 CO Impact Days and Initiative Showcase on March 4, 2016. The functional brain imaging and analytics company was chosen from more than 280 Colorado applicants to participate in the first of its kind, statewide marketplace for impact investing.
CereScan is a brain science and analytics company that includes what is believed to be the country’s largest and most complete functional brain imaging data warehouse. The CereMetrixTM database will unite the Company’s brain imaging with vital medical data to give practitioners access to the information needed to make better, faster diagnostic decisions for complex brain conditions.
CereScan, along with the other chosen ventures, will convene at the Ellie Caulkins Opera House at the Denver Center for the Performing Arts (DCPA) to meet face to face with accredited investors in order to seek millions of dollars of impact investments. The chosen social ventures will have the opportunity to showcase their ability to provide a return on the impact investor’s investment, while improving Colorado communities, to more than 200 accredited investors.
“This is the first time in the U.S. that 200 accredited impact investors will come together for a statewide marketplace, where they can connect with each other, learn, and have intimate access to social ventures representing projects, for profits, nonprofits, and funds at any stage of growth,” said Dr. Stephanie Gripne, Founder of the Impact Finance Center and creator of CO Impact Days and Initiative. “This is a first for impact investors and social ventures.”
The goal of CO Impact Initiative is to catalyze $100 million in impact investments into Colorado social ventures in the next three years, and it is kicking off with CO Impact Days on March 2-4. CO Impact Days encourages a new breed of impact investors and community members to Learn. Connect. Invest.
“The name of the gathering says it all,” said CereScan Chair and CEO, John Kelley. “CO Impact Days provides a unique platform for CereScan and similar socially conscious organizations to effectively connect with potential financial resources within our realm. Our success will undoubtedly have an impact on a local and a national scale in the area of brain diagnostics and clinical research into brain disorders.”
CO Impact Days’ innovation is uniquely possible because Colorado is home to a number of national leaders in impact investing and a thriving and collaborative community of social venture entrepreneurs in both the for profit and nonprofit sectors, philanthropists and investors who are committed to growing Colorado’s economy and creating valuable jobs while ensuring our state remains one of the best places to work, live, and play in the U.S.
Voting for the People’s Choice Award will close on Monday, February 29 at 5p.m. The company with the most votes will receive the Award on Friday, March 4th, which will include a five-minute presentation on the stage of the Ellie Caulkins Opera House! To advocate on behalf of CereScan, please cast your vote here (no sign-up required).
Among the more than 200 accredited impact investors, foundations, and family offices participating in CO Impact Days and Initiative are Gary Community Investments, Colorado Health Foundation, The Denver Foundation and Innovest Portfolio Solutions, along with Linda Appel Lipsius, Andrew C. Currie, Rich Hoops, Jim and Melanie Davidson, and Jenn Vervier.
About CO Impact Days and Initiative
CO Impact Days is the first of its kind effort to create a statewide marketplace for impact investing; identifying, connecting, and celebrating Colorado’s top social ventures and impact investors from the Western Slope to the Front Range. CO Impact Days’ will to bring together Colorado’s top 60 social ventures, 200 impact investors, and 500+ community members to Learn. Connect. Invest. For more information or tickets, visit www.coimpactdays.org or contact Molly at firstname.lastname@example.org.
CO Impact Initiative, created by the Impact Finance Center and led by Dr. Stephanie Gripne and a steering committee of community leaders is a 3-year strategy to elevate and accelerate impact investing in Colorado, catalyzing the flow of $100 million in investment capital into Colorado social ventures that deliver positive impact on the state’s communities, economy and natural environment.
Interesting linksHere are some interesting links for you! Enjoy your stay :)
- CereScan on Forbes: What Radiology Tech Can Learn From Baseball’s Electronic Strike Zone Debate
- How to Close the Gap Between Healthy Aging and Growing Old
- CereScan on Forbes.com: Using Data Analytics to Fight the Opioid Crisis
- CereScan is Now In-Network with United Healthcare Insurance
- CereScan CEO John Kelley accepted into Forbes Technology Council